Pfizer confirms COVID pill’s results, potency versus omicron

Pfizer is also studying its pill in lower-risk adults — including a subset who are vaccinated — but reported mixed data for that group on Tuesday.

from The Hindu - Home https://ift.tt/3EQ8rGm
https://ift.tt/2IyLjhI